Nalagenetics
Signal active
Organization
Contact Information
Overview
Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatal reactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic.
About
Industries
Biotechnology, Health Care, Medical
Founded
2016
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Nalagenetics headquartered in Asia, operates in the Biotechnology, Health Care, Medical sector. The company focuses on Biotechnology and has secured $979.2M in funding across 72 round(s). With a team of 11-50 employees, Nalagenetics is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Nalagenetics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
6
Investors
1
Lead Investors
0
Total Funding Amount
$13.6M
Details
2
Nalagenetics has raised a total of $13.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | 1.0M | ||
| 2022 | Early Stage Venture | 12.6M |
Investors
Nalagenetics is funded by 18 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Nalagenetics | - | FUNDING ROUND - Nalagenetics | undefined |
| Endeavor Indonesia | - | FUNDING ROUND - Endeavor Indonesia | undefined |
| Nalagenetics | - | FUNDING ROUND - Nalagenetics | undefined |
| Cedars-Sinai Accelerator | - | FUNDING ROUND - Cedars-Sinai Accelerator | undefined |
Recent Activity
There is no recent news or activity for this profile.